PRISMA AI reporting guidelines for systematic reviews and meta-analyses on AI in healthcare
Giovanni E. Cacciamani,Timothy N. Chu,Daniel I. Sanford,Andre Abreu,Vinay Duddalwar,Assad Oberai,C.-C. Jay Kuo,Xiaoxuan Liu,Alastair K. Denniston,Baptiste Vasey,Peter McCulloch,Robert F. Wolff,Sue Mallett,John Mongan,Charles E. Kahn,Viknesh Sounderajah,Ara Darzi,Philipp Dahm,Karel G. M. Moons,Eric Topol,Gary S. Collins,David Moher,Inderbir S. Gill,Andrew J. Hung
DOI: https://doi.org/10.1038/s41591-022-02139-w
IF: 82.9
2023-01-17
Nature Medicine
Abstract:Systematic reviews and meta-analyses play an essential part in guiding clinical practice at the point of care, as well as in the formulation of clinical practice guidelines and health policy 1,2 . There are three essential components to an impactful systematic review. First, the design of a study should be based upon a robust research question and search strategy. Second, minimization of bias should be enhanced by using quality-assessment tools and study-design-specific eligibility criteria. Third, reporting of results should be conducted transparently through adherence to expert-derived reporting items. Thousands of systematic reviews, including meta-analyses, are produced annually, with an increasing proportion reporting on artificial intelligence (AI) interventions in health care. With this rapid expansion, there is a need for reporting guidelines tailored to AI 3,4,5,6,7 that will support high-quality, reproducible, and clinically relevant systematic reviews.
biochemistry & molecular biology,cell biology,medicine, research & experimental